Press Release: VCLS Appoints Carole Jones, Director, Market Access

The appointment of Carole Jones demonstrates VCLS’s commitment to the expansion of their Market Access capabilities. With over 20 years’ experience in the Healthcare industry, Ms Jones will deliver strategic counsel to support clients’ efforts to provide patient access to their new and novel products.

Paris, France, May 15, 2017
Voisin Consulting Life Science - Paris, France

read more

Digital and patient centred innovation in healthcare: Science fiction or tomorrow’s reality?

12 June, 2015 - 1.00 pm CEST

Christophe Amiel, Senior Director, Voisin Consulting Life Sciences, will be a key speaker in conjunction with three other speakers [from Bluemorpho and the Innovative Medicines Initiative (IMI) respectively] presenting a webinar titled, "Digital and patient centred innovation in healthcare: Science fiction or tomorrow’s reality?".

read more

Preparing a drug registration for the US and the EU: Parallel or sequential applications? – Part 2

June, 2015
Voisin Consulting Life Science - 3, rue des Longs Prés 92100 Boulogne

Submitting a new drug application (NDA) or a biologic license application (BLA) in the US or a marketing authorisation application (MAA) in the EU is the ultimate goal of all sponsors and a mandatory step for the commercialisation of any medicinal products.

read more

The challenges of potency assay development for cell-based medicinal products in Europe

May, 2015
Voisin Consulting Life Science - 3, rue des Longs Prés 92100 Boulogne

Developing the relevant set of potency assays for cell-based medicinal products comes with numerous challenges due to the complex nature of the products. Potency is considered a critical quality attribute (CQA) for any biological product, and the implementation of relevant assays is often at the centre of many challenges and discussions among developers and regulators throughout product development.

read more

Pages